A Study of Tirzepatide in Overweight and Very Overweight Participants

Clinical trial NCT04311411 · COMPLETED

Trial details

NCT number: NCT04311411
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Obesity Overweight

Start date: 2020-08-24
Primary completion: 2022-12-16
Enrollment: 114

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.